Erection problems less in men who have intercourse more often Men's Health News Having intercourse more often may help prevent the development of erectile dysfunction (ED).A study published in the July 2008 issue of The American Journal of Medicine reports that researchers have found that men who...
Increased Risk Of Kidney Stones And Gastric Bypass Surgery Linked Current Article Ratings: Patient / Public: Health Professional: Article Opinions: 0 posts Morbidly obese patients who undergo a particular type of gastric bypass surgery called Roux-en-Y gastric bypass (RYGB) are at an increased risk of...
Gastric bypass linked to greater risk of kidney stones Morbidly obese patients who undergo a particular type of gastric bypass surgery called Roux-en-Y gastric bypass (RYGB) are at an increased risk of developing kidney stones - small, pebble-like deposits that can result in severe pain and...
Study links gastric bypass surgery to increased risk of kidney stones Morbidly obese patients who undergo a particular type of gastric bypass surgery called Roux-en-Y gastric bypass (RYGB) are at an increased risk of developing kidney stones small, pebble-like deposits that can result in severe pain and...
Urologic Surgical Pathology, EXPERT Consult: Online and Print, 2nd Edition Completely revised with practical guidance in daily urological pathology sign-out and the latest recommended diagnostic approaches, the new edition of this comprehensive reference equips you to accurately diagnose specimens of the entire...
Researchers seek children for a study of antibiotics for a urinary tract disorder Researchers conducting a study to learn if children with a urinary tract disorder known as vesicoureteral reflux (VUR) should be treated with an antibiotic for an extended period of time are seeking to enroll more participants.The study,...
Prostate cancer options to be discussed ,me %%webhead%% %%ewebhead%% BEACHWOOD Prostate cancer options Dr.Eric Klein, head of urologic oncology at the Glickman Urologic Institute of the Cleveland Clinic, will discuss the latest treatment options for men with prostate...
New Take on a Prostate Drug, and a New Debate Peter Scardino, chairman of the department of surgery at Memorial Sloan-Kettering Cancer Center, originally thought finasteride was dangerous but now recommends its use.Gianni Cipriano for The New York Times For the first time, leading...
Specialists Debate Using Prostate Drug To Prevent Cancer For the first time, leading prostate cancer specialists say, they have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent.But the discovery, arising from a new analysis of a large...
Drug could reduce prostate cancer rate Leading prostate cancer specialists say they now have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent.But the discovery, arising from a new analysis of a large federal study,...
Drug cuts risk of prostate cancer by 30%, study shows For the first time, leading prostate cancer specialists say they have a drug that can significantly cut men's risk of developing the disease, dropping the incidence by 30 percent.But the discovery, arising from a new analysis of a large...
New Take on a Prostate Drug, and a New Debate Peter Scardino, chairman of the department of surgery at Memorial Sloan-Kettering Cancer Center, originally thought finasteride was dangerous but now recommends its use.For the first time, leading prostate cancer specialists say, they...
Prostate cancer drug hailed, but experts debate use Many cases could be prevented, but possible side effects later are unknown New York Times TOOLS RESOURCES Get section feed DRUG BLOCKS ACTIVE HORMONE Finasteride blocks the conversion of testosterone to dihydrotestosterone, a hormone active...
BCG caution advised in elderly MedWire News: Maintenance therapy with intravesical bacillus Calmette-Gurin (BCG) should be given with caution in patients over 70 years of age, US researchers warn.BCG, an inactivated form of the bacterium Mycobacterium tuberculosis,...
Urologic Cancer Patients Benefiting from Robot-Assisted Surgery Newswise Dipen Parekh, M.D., a urologic oncologist at The , deftly operates the handles and pedals of a console located 6 feet away from his patient's operating table.The handles and pedals control robotic arms positioned above the...
Shop Talk Joseph V.Simone, MD, has been named Director of the new University of Florida Shands Cancer Center and Physician-in-Chief of Cancer Services for Shands at UF, starting on July 1.
Simone, a member of OT's Editorial Board, who has been...
FISH assay predicts bladder cancer recurrence MedWire News: A multitargeted fluorescent in-situ hybridization (FISH) assay can predict tumor recurrence in patients with a history of bladder cancer and no signs of disease, US researchers report.UroVysion (Abbott Molecular Inc, Des...
Medivation Announces Presentation Of Positive MDV3100 Clinical Data In Castration-Resistant Prostate Cancer Pa Current Article Ratings: Patient / Public: Health Professional: Article Opinions: 0 posts Medivation, Inc.(Nasdaq: MDVN) announced that data from an ongoing Phase 1-2 clinical trial of the Company's novel androgen receptor antagonist,...
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Pa - Observed Dose-Response Trends Suggest Improved Efficacy with Higher Doses - SAN FRANCISCO and CHICAGO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.today announced that data from an ongoing Phase 1-2 clinical trial of the Company's...
UroToday International Journal Opens No Cost Online Manuscript Submission UroToday International Journal(R) (UIJ) (http://www.urotodayinternationaljournal.com), a new online, peer-reviewed, fast-tracked urology and urologic oncology publication, opened the online submission portal, http://www.edmgr.com/uij.
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Pa - Observed Dose-Response Trends Suggest Improved Efficacy with Higher Doses - SAN FRANCISCO and CHICAGO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.today announced that data from an ongoing Phase 1-2 clinical trial of the Company's...
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Pa - Observed Dose-Response Trends Suggest Improved Efficacy with Higher Doses - SAN FRANCISCO and CHICAGO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.today announced that data from an ongoing Phase 1-2 clinical trial of the Company's...
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Pa - Observed Dose-Response Trends Suggest Improved Efficacy with Higher Doses - SAN FRANCISCO and CHICAGO, June 02, 2008 /PRNewswire-FirstCall/ -- Medivation, Inc.today announced that data from an ongoing Phase 1-2 clinical trial of the...
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Pa SAN FRANCISCO and CHICAGO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.(Nasdaq: MDVN - News) today announced that data from an ongoing Phase 1-2 clinical trial of the Company's novel androgen receptor antagonist, MDV3100, showed...
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Pa SAN FRANCISCO and CHICAGO, June 2 /PRNewswire-FirstCall/ -- Medivation, Inc.MDVN today announced that data from an ongoing Phase 1-2 clinical trial of the Company's novel androgen receptor antagonist, MDV3100, showed encouraging anti...
